Nice work @brian_rifkin @NephJC for featuring this important work by @ShrutiGkidney @Api_chew and team.
As a former Neph JC intern, this is pretty cool!
@onconephsociety
@MGBKidneys
@DanaFarber
@harvardmed
As a former Neph JC intern, this is pretty cool!
@onconephsociety
@MGBKidneys
@DanaFarber
@harvardmed
PLEX or daratumumab for myeloma cast nephropathy? A 549-patient target trial emulation found neither linked to better kidney recovery at 90 days. Glimmer of hope or mirage?View quoted post on X
⬇️New #NephJC Short by @brian_rifkin
nephjc.com/news/daravsple…